The Innovations in Alzheimer’s Research Sharon Francis Memorial Fund supports forward-thinking projects in regenerative medicine with a focus on Alzheimer’s disease, including studies that aim to characterize, detect, or treat the condition. Projects with a viable path to clinical translation are preferred. It supports projects with a specific purpose and a defined endpoint.
Grants are issued following a competitive, peer review process and are valued up to $75,000 CDN per year, for a 2-year funding period, i.e. total value up to $150,000 CDN per project.
For more information, please see the Innovations in Alzheimer’s Research Sharon Francis Memorial Fund Guidelines.
OPEN: We are currently accepting applications for the 2020 competition
Interested applicants must submit a Notice of Intent (NOI). Applicants with high potential projects will be invited to submit a Full Application. Full Applications will be reviewed by an expert peer review panel, and the project with the most potential and impact will be selected to receive funding.
To apply, please see the Innovations in Alzheimer’s Research Sharon Francis Memorial Fund NOI Application.
NOIs are due Friday, March 6, 2020 by 4:00 pm EST.
For any questions, please email [email protected] or call the SFIRM team at 416-350-5900 x2890.
The Brain Regenerative Discovery Fund supports innovative projects in stem cell and regenerative medicine with a focus on the brain. Projects that accelerate knowledge related to brain degenerative conditions, specifically those which aim to address an unmet need, are preferred. It supports projects with a specific purpose and a defined endpoint.
The grant competition was launched in March 2019 and is now closed.
The inaugural Brain Regenerative Discovery Fund recipient will be announced in September 2019.